Bicycle Therapeutics (BCYC) Short Interest Ratio & Short Volume $8.56 +0.52 (+6.47%) Closing price 04:00 PM EasternExtended Trading$8.31 -0.25 (-2.92%) As of 07:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Bicycle Therapeutics Short Interest DataBicycle Therapeutics (BCYC) has a short interest of 2.60 million shares, representing 4.87% of the float (the number of shares available for trading by the public). This marks a 4.84% increase in short interest from the previous month. The short interest ratio (days to cover) is 7.6, indicating that it would take 7.6 days of the average trading volume of 399,049 shares to cover all short positions.Current Short Interest2,600,000 sharesPrevious Short Interest2,480,000 sharesChange Vs. Previous Month+4.84%Dollar Volume Sold Short$18.07 millionShort Interest Ratio7.6 Days to CoverLast Record DateJune 30, 2025Outstanding Shares69,250,000 sharesShort Percent of Float4.87%Today's Trading Volume501,623 sharesAverage Trading Volume399,049 sharesToday's Volume Vs. Average126% Short Selling Bicycle Therapeutics? Sign up to receive the latest short interest report for Bicycle Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBCYC Short Interest Over TimeBCYC Days to Cover Over TimeBCYC Percentage of Float Shorted Over Time Bicycle Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/20252,600,000 shares $18.07 million +4.8%4.9%7.6 $6.95 6/15/20252,480,000 shares $20.76 million -28.1%4.6%7.1 $8.37 5/31/20253,450,000 shares $28.36 million +3.6%5.5%9.7 $8.22 5/15/20253,330,000 shares $27.04 million +8.8%5.3%9.2 $8.12 4/30/20253,060,000 shares $26.19 million -2.2%N/A8.6 $8.56 4/15/20253,130,000 shares $24.38 million -27.2%5.0%9 $7.79 3/31/20254,300,000 shares $36.51 million -2.3%6.8%13 $8.49 3/15/20254,400,000 shares $42.64 million +4.3%7.0%13.2 $9.69 2/28/20254,220,000 shares $46.29 million -0.9%6.7%8.7 $10.97 2/15/20254,260,000 shares $53.46 million -0.9%6.7%8.3 $12.55 Get the Latest News and Ratings for BCYC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bicycle Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20254,300,000 shares $57.58 million +0.5%N/A7.9 $13.39 1/15/20254,280,000 shares $62.27 million +8.6%N/A7.7 $14.55 12/31/20243,940,000 shares $55.16 million +14.9%N/A6.7 $14.00 12/15/20243,430,000 shares $47.37 million +1.2%N/A5.8 $13.81 11/30/20243,390,000 shares $69.16 million -3.7%N/A7.2 $20.40 11/15/20243,520,000 shares $76.70 million +7.7%N/A7.8 $21.79 10/31/20243,270,000 shares $76.67 million +12.0%N/A8.1 $23.45 10/15/20242,920,000 shares $79.10 million +10.2%N/A7.6 $27.09 9/30/20242,650,000 shares $59.97 million +12.3%N/A8.1 $22.63 9/15/20242,360,000 shares $63.77 million +12.4%N/A8.1 $27.02 8/31/20242,100,000 shares $45.15 million -4.6%N/A8.3 $21.50 8/15/20242,200,000 shares $49.98 million +6.3%N/A7.7 $22.72 7/31/20242,070,000 shares $50.32 million -23.1%N/A7.3 $24.31 7/15/20242,690,000 shares $60.79 million -4.3%N/A9.3 $22.60 6/30/20242,810,000 shares $56.87 million +1.1%N/A8.8 $20.24 6/15/20242,780,000 shares $64.22 million +6.1%N/A7.6 $23.10 5/31/20242,620,000 shares $58.14 million -9.3%N/A6.9 $22.19 5/15/20242,890,000 shares $64.62 million +3.6%N/A7.5 $22.36 4/30/20242,790,000 shares $65.43 million -5.7%N/A7 $23.45 4/15/20242,960,000 shares $64.59 million +16.5%N/A7.4 $21.82 3/31/20242,540,000 shares $63.25 million -0.8%N/A6.6 $24.90 3/15/20242,560,000 shares $60.83 million -7.3%N/A7.1 $23.76 2/29/20242,760,000 shares $69.25 million -18.6%N/A6.1 $25.09 2/15/20243,390,000 shares $74.89 million -10.3%N/A7.2 $22.09 1/31/20243,780,000 shares $65.96 million -1.8%N/A7.9 $17.45 1/15/20243,850,000 shares $71.03 million -0.5%N/A7.1 $18.45 12/31/20233,870,000 shares $69.97 million -4.2%N/A7 $18.08 12/15/20234,040,000 shares $70.74 million -2.7%N/A7.3 $17.51 11/30/20234,150,000 shares $59.76 million +3.8%N/A8.5 $14.40 11/15/20234,000,000 shares $61.56 million -8.5%N/A9.2 $15.39Missed the Run So Far? This Is Your Second Chance (Ad)According to history, the final stretch of the crypto cycle is here — and this short window is where fortunes are made. Inside The Crypto Code Workshop, two experts reveal how to get positioned early, lock in profits, and access their top altcoin picks before the crowd. All attendees receive $10 in free Bitcoin just for showing up. Join The Crypto Code Workshop + get $10 in Bitcoin for attending 10/31/20234,370,000 shares $65.77 million -1.4%N/A10.8 $15.05 10/15/20234,430,000 shares $89.57 million -7.3%N/A12.7 $20.22 9/30/20234,780,000 shares $96.03 million +5.5%N/A14.1 $20.09 9/15/20234,530,000 shares $94.41 million +3.7%N/A14.4 $20.84 8/31/20234,370,000 shares $95.00 million +7.6%N/A16.7 $21.74 8/15/20234,060,000 shares $88.35 million +8.6%N/A17 $21.76 7/31/20233,740,000 shares $92.00 million -13.2%N/A16.7 $24.60 7/15/20234,310,000 shares $112.97 million +1.7%N/A21.7 $26.21 6/30/20234,240,000 shares $108.20 million +1.7%N/A23.8 $25.52 6/15/20234,170,000 shares $110.96 million -0.7%N/A17.9 $26.61 5/31/20234,200,000 shares $100.72 million -0.9%N/A15.5 $23.98 5/15/20234,240,000 shares $101.21 million +15.2%N/A14.7 $23.87 4/30/20233,680,000 shares $72.72 million +5.1%N/A10.8 $19.76 4/15/20233,500,000 shares $66.33 million +0.3%N/A10 $18.95 3/31/20233,490,000 shares $74.23 million +14.4%N/A10 $21.27 3/15/20233,050,000 shares $65.54 million -2.9%N/A10.3 $21.49 2/28/20233,140,000 shares $71.37 million +53.9%N/A10.8 $22.73 2/15/20232,040,000 shares $50.29 million +8.5%N/A7.2 $24.65 1/31/20231,880,000 shares $51.93 million +0.5%N/A7.6 $27.62 1/15/20231,870,000 shares $52.04 million -5.6%N/A8.2 $27.83 12/30/20221,980,000 shares $58.61 million -10.4%N/A8.5 $29.60 12/15/20222,210,000 shares $69.11 million -14.3%N/A9.6 $31.27 11/30/20222,580,000 shares $74.72 million +1.2%N/A10.9 $28.96 11/15/20222,550,000 shares $72.01 million -8.6%N/A11.7 $28.24 10/31/20222,790,000 shares $69.05 million -14.9%N/A12.8 $24.75 10/15/20223,280,000 shares $71.80 million +7.2%N/A15 $21.89 9/30/20223,060,000 shares $71.18 million +5.2%N/A13.9 $23.26 9/15/20222,910,000 shares $71.53 million +1.4%N/A11 $24.58 8/31/20222,870,000 shares $75.91 million No ChangeN/A9.4 $26.45 8/15/20222,870,000 shares $75.77 million -1.4%N/A8.8 $26.40 7/31/20222,910,000 shares $68.56 million -2.0%N/A7.5 $23.56 7/15/20222,970,000 shares $62.31 million +10.8%N/A6.9 $20.98 6/30/20222,680,000 shares $44.97 million +18.6%N/A4.1 $16.78 6/15/20222,260,000 shares $30.49 million -6.2%N/A3.6 $13.49 5/31/20222,410,000 shares $38.54 million -2.4%N/A4 $15.99 5/15/20222,470,000 shares $42.85 million +27.3%N/A4.3 $17.35 4/30/20221,940,000 shares $45.55 million +10.9%N/A3.8 $23.48 4/15/20221,750,000 shares $42.02 million +230.0%N/A3.9 $24.01 3/31/2022530,300 shares $23.27 million +16.2%N/A1.8 $43.88 3/15/2022456,300 shares $19.20 million -3.8%N/A2.1 $42.07 2/28/2022474,100 shares $22.52 million -1.6%N/A2.2 $47.50 2/15/2022481,700 shares $23.16 million -8.3%N/A2.3 $48.08 1/31/2022525,500 shares $25.66 million +40.2%N/A2.4 $48.83 1/15/2022374,900 shares $18.16 million -32.7%N/A1.6 $48.44 12/31/2021556,900 shares $33.90 million +7.4%N/A1.9 $60.87 12/15/2021518,400 shares $26.85 million +5.5%N/A1.5 $51.80 11/30/2021491,300 shares $26.41 million +2.2%N/A1.4 $53.75 11/15/2021480,800 shares $29.40 million +8.4%N/A1.4 $61.14 10/29/2021443,400 shares $22.79 million +44.5%N/A1.4 $51.40 10/15/2021306,900 shares $18.20 million -33.1%N/A1 $59.29Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow 9/30/2021458,700 shares $19.08 million +6.4%2.0%1.7 $41.59 9/15/2021431,000 shares $18.87 million -7.8%1.9%2.5 $43.78 8/31/2021467,300 shares $16.68 million +9.3%2.0%3 $35.70 8/13/2021427,600 shares $12.22 million -11.0%2.0%3.6 $28.59 7/30/2021480,200 shares $15.17 million +4.4%2.2%4.1 $31.60 7/15/2021460,200 shares $15.62 million +7.4%2.2%4.4 $33.95 6/30/2021428,700 shares $13.02 million -0.1%2.0%5 $30.36 6/15/2021429,300 shares $12.90 million +0.5%2.0%3.9 $30.05 5/28/2021427,000 shares $12.60 million -0.9%2.0%3.7 $29.50 5/14/2021431,000 shares $12.82 million +6.7%N/A2.9 $29.75 4/30/2021404,000 shares $12.04 million -11.7%N/A2.6 $29.80 4/15/2021457,300 shares $13.70 million +6.1%N/A2.9 $29.96 3/31/2021431,000 shares $11.58 million -2.4%N/A2.3 $26.87 3/15/2021441,500 shares $12.31 million +10.4%N/A3 $27.88 2/26/2021400,100 shares $9.98 million +0.8%N/A3 $24.94 2/12/2021397,100 shares $11.01 million +7.4%N/A3.2 $27.72 1/29/2021369,700 shares $9.72 million +4.6%N/A3.6 $26.29 1/15/2021353,300 shares $9.01 million +6.2%N/A3.7 $25.50 12/31/2020332,800 shares $6.18 million +6.8%N/A6 $18.57 12/15/2020311,600 shares $5.94 million +4.5%N/A5.6 $19.06 11/30/2020298,200 shares $6.10 million +8.4%N/A3.5 $20.44 11/15/2020275,100 shares $5.59 million +0.5%1.6%3.5 $20.32 10/30/2020273,700 shares $5.14 million +4.8%1.6%3.7 $18.79 10/15/2020261,200 shares $4.94 million +12.9%1.8%3.6 $18.93 9/30/2020231,300 shares $4.41 million +22.9%1.6%3.5 $19.05 9/15/2020188,200 shares $3.58 million +22.0%1.3%2.5 $19.03 8/31/2020154,300 shares $2.77 million +17.6%1.0%3.3 $17.97 8/14/2020131,200 shares $2.24 million +21.5%0.9%2.8 $17.06 7/31/2020108,000 shares $1.71 million +4.6%0.7%2.3 $15.80 BCYC Short Interest - Frequently Asked Questions What is Bicycle Therapeutics' current short interest? Short interest is the volume of Bicycle Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 2,600,000 shares of BCYC short. 4.87% of Bicycle Therapeutics' shares are currently sold short. Learn More on Bicycle Therapeutics' current short interest. What is a good short interest ratio for Bicycle Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BCYC shares currently have a short interest ratio of 8.0. Learn More on Bicycle Therapeutics's short interest ratio. Which institutional investors are shorting Bicycle Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Bicycle Therapeutics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Bicycle Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.87% of Bicycle Therapeutics' floating shares are currently sold short. Is Bicycle Therapeutics' short interest increasing or decreasing? Bicycle Therapeutics saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 2,600,000 shares, an increase of 4.8% from the previous total of 2,480,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Bicycle Therapeutics' short interest compare to its competitors? 4.87% of Bicycle Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Bicycle Therapeutics: Indivior PLC (7.18%), Recursion Pharmaceuticals, Inc. (35.52%), Denali Therapeutics Inc. (9.91%), Beam Therapeutics Inc. (24.82%), Kiniksa Pharmaceuticals International, plc (6.10%), Belite Bio, Inc. Sponsored ADR (0.60%), Centessa Pharmaceuticals PLC Sponsored ADR (4.53%), Vericel Corporation (4.89%), Disc Medicine, Inc. (14.58%), Harmony Biosciences Holdings, Inc. (10.14%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Bicycle Therapeutics stock? Short selling BCYC is an investing strategy that aims to generate trading profit from Bicycle Therapeutics as its price is falling. BCYC shares are trading up $0.52 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bicycle Therapeutics? A short squeeze for Bicycle Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BCYC, which in turn drives the price of the stock up even further. How often is Bicycle Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCYC, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies INDV Short Interest RXRX Short Interest DNLI Short Interest BEAM Short Interest KNSA Short Interest BLTE Short Interest CNTA Short Interest VCEL Short Interest IRON Short Interest HRMY Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BCYC) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bicycle Therapeutics PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Bicycle Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BCYC Stock Alerts